Page 98 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
T2D polymorphisms in Asians

doi: 10.1016/j.cmet.2016.04.009 gene are associated with the therapeutic responses of
sulfonylureas in Chinese patients with type 2 diabetes. Acta
68. Lyssenko V, Nagorny CLF, Erdos MR, et al. Common
variant in MTNR1B associated with increased risk of type 2 Pharmacol Sin. 2017;38(1):80-89.
diabetes and impaired early insulin secretion. Nat Genet. doi: 10.1038/aps.2016.103
2009;41(1):82-88.
79. Xu J, Zhang W, Song W, et al. Relationship between KCNQ1
doi: 10.1038/ng.288 polymorphism and type 2 diabetes risk in Northwestern
69. Liu C, Wu Y, Li H, et al. MTNR1B rs10830963 is associated China. Pharmgenomics Pers Med. 2021;14:1731-1751.
with fasting plasma glucose, HbA1Cand impaired beta-cell doi: 10.2147/PGPM.S340813
function in Chinese Hans from Shanghai. BMC Med Genet.
2010;11:59. 80. Yu XX, Liao MQ, Zeng YF, et al. Associations of KCNQ1
polymorphisms with the risk of type 2 diabetes mellitus:
doi: 10.1186/1471-2350-11-59 An updated meta-analysis with trial sequential analysis.
70. Ramírez AV, Flores-Saiffe Farías A, Chávez Álvarez RD, J Diabetes Res. 2020;2020:7145139.
Prado Montes de Oca E. Predicted regulatory SNPs reveal doi: 10.1155/2020/7145139.
potential drug targets and novel companion diagnostics in
psoriasis. J Transl Autoimmun. 2021;4:100096. 81. Shorokhova P, Baranov V, Vorokhobina N. Abstract
#1001320: Effects of KCNJ11 RS5219 variant on metformin
doi: 10.1016/j.jtauto.2021.100096 pharmacodynamics in patients with newly diagnosed type 2
71. Zhang LF, Pei Q, Yang GP, et al. The effect of IGF2BP2 gene diabetes mellitus. Endocr Pract. 2021;27:S39.
polymorphisms on pioglitazone response in Chinese type 2 doi: 10.1016/j.eprac.2021.04.553
diabetes patients. Pharmacology. 2014;94(3-4):115-122.
82. Reddy S, Maddhuri S, Nallari P, et al. Association of ABCC8
doi: 10.1159/000363414 and KCNJ11 gene variants with type 1 diabetes in south
72. Huang Q, Yin JY, Dai XP, et al. IGF2BP2 variations influence Indians. Egypt J Med Hum Genet. 2021;22:27.
repaglinide response and risk of type 2 diabetes in Chinese doi: 10.1186/s43042-021-00149-w
population. Acta Pharmacol Sin. 2010;31(6):709-717.
83. Huang Q, Yin JY, Dai XP, et al. Association analysis of
doi: 10.1038/aps.2010.47 SLC30A8 rs13266634 and rs16889462 polymorphisms with
73. Dujic T, Bego T, Malenica M, et al. Effects of TCF7L2 type 2 diabetes mellitus and repaglinide response in Chinese
rs7903146 variant on metformin response in patients with patients. Eur J Clin Pharmacol. 2010;66:1207-1215.
type 2 diabetes. Bosn J Basic Med Sci. 2019;19(4):368-374. doi: 10.1007/s00228-010-0882-6
doi: 10.17305/bjbms.2019.4181 84. Zheng X, Ren W, Zhang S, et al. Association of type 2
74. Wang J, Kuusisto J, Vänttinen M, et al. Variants of transcription diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1
factor 7-like 2 (TCF7L2) gene predict conversion to type 2 and PCSK2) and proinsulin conversion in a Chinese
diabetes in the Finnish Diabetes Prevention Study and are population. Mol Biol Rep. 2012;39(1):17-23.
associated with impaired glucose regulation and impaired doi: 10.1007/s11033-011-0705-6
insulin secretion. Diabetologia. 2007;50(6):1192-1200.
85. Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact
doi: 10.1007/s00125-007-0656-6 of common variants of PPARG, KCNJ11, TCF7L2,
75. Spainhour JC, Lim HS, Yi SV, Qiu P. Correlation patterns SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1
between DNA methylation and gene expression in the cancer on the risk of type 2 diabetes in 5,164 Indians. Diabetes.
genome atlas. Cancer Inform. 2019;18:1176935119828776. 2010;59(8):2068-2074.
doi: 10.1177/1176935119828776 doi: 10.2337/db09-1386
76. Dhawan D, Padh H. Genetic variations in TCF7L2 influence 86. Tabara Y, Osawa H, Kawamoto R, et al. Replication study
therapeutic response to sulfonylureas in Indian diabetics. of candidate genes associated with type 2 diabetes based on
Diabetes Res Clin Pract. 2016;121:35-40. genome-wide screening. Diabetes. 2009;58(2):493-498.
doi: 10.1016/j.diabres.2016.08.018 doi: 10.2337/db07-1785
77. Zhou X, Zhu J, Bao Z, et al. A variation in KCNQ1 87. Li Y, Wang X, Lu X. KCNQ 1 rs2237892 C→T gene
gene is associated with repaglinide efficacy on insulin polymorphism and type 2 diabetes mellitus in the Asian
resistance in Chinese Type 2 diabetes mellitus patients. Sci population: A meta‐analysis of 15,736 patients. J Cell Mol
Rep. 2016;6:37293. Med. 2014;18(2):274-282.
doi: 10.1038/srep37293 doi: 10.1111/jcmm.12185
78. Li Q, Tang TT, Jiang F, et al. Polymorphisms of the KCNQ1 88. Tan JT, Ng DP, Nurbaya S, et al. Polymorphisms identified

Volume 9 Issue 1 (2025) 90 doi: 10.36922/ejmo.7549